Global Cell And Gene Therapy Cdmo Market Size & Outlook
Global cell and gene therapy cdmo market, 2021-2033 (US$M)
Related Markets
Global cell and gene therapy cdmo market highlights
- The global cell and gene therapy cdmo market generated a revenue of USD 4,309.7 million in 2024 and is expected to reach USD 27,123.2 million by 2033.
- The market is expected to grow at a CAGR (2025 - 2033) of 23% by 2033.
- In terms of segment, pre-clinical accounted for a revenue of USD 3,357.1 million in 2024.
- Pre-clinical is the most lucrative phase segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, Italy is expected to register the highest CAGR from 2025 to 2033.
Global data book summary
| Market revenue in 2024 | USD 4,309.7 million |
| Market revenue in 2033 | USD 27,123.2 million |
| Growth rate | 23% (CAGR from 2025 to 2033) |
| Largest segment | Pre-clinical |
| Fastest growing segment | Pre-clinical |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pre-clinical, Clinical |
Other key industry trends
- In terms of revenue, the North America accounted for 40.8% of the global cell and gene therapy cdmo market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, Italy is the fastest growing regional market and is projected to reach USD 1,096.5 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell And Gene Therapy CDMO Market Scope
Cell And Gene Therapy CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Cytiva | View profile | 10001+ | Marlborough, Massachusetts, United States, North America | https://www.cytivalifesciences.com/en/us |
| Rentschler Biopharma SE | View profile | 501-1000 | Laupheim, Baden-Wurttemberg, Germany, Europe | https://www.rentschler-biopharma.com |
| Catalent Inc | View profile | 17219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | https://www.catalent.com |
| AGC Inc | View profile | 61671 | 1-5-1, Marunouchi, Chiyoda-ku, Tokyo, Japan, 100-8405 | https://www.agc.com |
| Wuxi AppTec Co Ltd | View profile | 41116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | https://www.wuxiapptec.com |
| OmniAb Inc | View profile | 106 | 5980 Horton Street, Suite 600, Emeryville, CA, United States, 94608 | https://www.omniab.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Samsung Electronics Co Ltd | View profile | 124804 | 129, Samsung-ro, Yeongtong-gu, Gyeonggi-do, Suwon-si, Korea, Republic of, 443-742 | https://www.samsung.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Global cell and gene therapy cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell and gene therapy cdmo market will help companies and investors design strategic landscapes.
Pre-clinical was the largest segment with a revenue share of 77.9% in 2024. Horizon Databook has segmented the Global cell and gene therapy cdmo market based on pre-clinical, clinical covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Cell And Gene Therapy CDMO Phase Outlook (Revenue, USD Million, 2021-2033)
- Pre-clinical
- Clinical
- Global Cell And Gene Therapy CDMO Product Type Outlook (Revenue, USD Million, 2021-2033)
- Gene Therapy
- Ex-vivo
- In-vivo
- Cell Therapy
- Gene-Modified Cell Therapy
- CAR T-cell therapies
- TCR-T cell therapy
- Other
- CAR-NK cell therapy
- Gene Therapy
- Global Cell And Gene Therapy CDMO Indication Outlook (Revenue, USD Million, 2021-2033)
- Oncology
- Neurological disorders
- Infectious Diseases
- Rare Diseases
- Others
Reasons to subscribe to Global cell and gene therapy cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global cell and gene therapy cdmo market databook
-
Our clientele includes a mix of cell and gene therapy cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global cell and gene therapy cdmo market , including forecasts for subscribers. This global databook contains high-level insights into Global cell and gene therapy cdmo market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global cell and gene therapy cdmo market size, by regions, 2021-2033 (US$M)
Top 10 countries: Cell and gene therapy cdmo market size, 2024 (US$M)
Global cell and gene therapy cdmo market share, by indication, 2024 & 2033 (%, US$M)
Cell and gene therapy cdmo market: Opportunity assessment by country
Global cell and gene therapy cdmo market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
